Keywords: s-p, 4th-qtr, results, hit, organon, buy, drug
S-P's 4th-qtr 2007 results hit by Organon buy
Article | 18 February 2008
US drug major Schering-Plough's fourth-quarter 2007 results were hit by costs related to last year's acquisition of Organon BioSciences from Netherlands-based ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
